Merck & Co Inc
NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024
MRK Articles
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Here is a slate of 15 companies that most retirees likely would want to own in their portfolio now, including AT&T, Boeing, Pfizer and Walmart.
Published:
Last Updated:
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
Published:
Last Updated:
According to Credit Suisse, Pfizer investors might be getting to make up some of that relative underperformance of late.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
Published:
Last Updated:
Stock buybacks have come under more scrutiny by the public and politicians in recent years, but companies still aggressively are buying back shares of their own stock.
Published:
Last Updated:
During times of uncertainty and fear, many investors have to look for a place to hide when they know that they have to keep having income from investments to supplement their income, retirement or...
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
These five outstanding ideas from Merrill Lynch are decidedly more conservative. Given their strong and consistent dividends, they offer investors excellent total return potential and a safer way to...
Published:
Last Updated:
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and...
Published:
Last Updated:
Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some might call a ridiculous premium
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Airlines, S&P, Transocean and Walmart.
Published:
Last Updated:
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those who are retired now or are within a decade of retiring.
Published:
Last Updated: